Fulgent Genetics, Inc.
FLGT
$18.59
$0.693.86%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 59.80% | -68.17% | 35.30% | 89.50% | -877.71% |
| Total Depreciation and Amortization | 4.59% | -3.79% | -7.65% | 1.99% | 1.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -55.06% | 101.28% | 2.93% | -92.75% | 349.48% |
| Change in Net Operating Assets | 162.86% | -896.98% | -152.63% | -52.03% | 191.55% |
| Cash from Operations | 261.31% | -461.94% | -41.03% | -51.34% | 45.83% |
| Capital Expenditure | 80.66% | -50.93% | -219.13% | -30.59% | 36.91% |
| Sale of Property, Plant, and Equipment | -100.00% | 123.53% | -93.41% | -22.99% | 1,422.73% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -183.12% | 40.79% | 146.63% | -258.12% | 9.85% |
| Cash from Investing | -405.56% | 23.01% | 115.48% | -294.42% | 20.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 77.41% | 33.11% | 54.43% | -12.28% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 43.85% | 20.77% | 71.47% | 92.05% | -783.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42.33% | 50.52% | 59.17% | 89.18% | -480.04% |
| Foreign Exchange rate Adjustments | -185.35% | 1,844.44% | 86.96% | -147.59% | 225.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.21% | -166.46% | 124.38% | -419.44% | -47.93% |
